X. Zheng

发表

Nutritional control of cell growth via TOR signaling in budding yeast.

Yuehua Wei, X. Zheng, X F Steven Zheng, 2011, Methods in molecular biology.

Opposing Role of Condensin and Radiation-sensitive Gene RAD52 in Ribosomal DNA Stability Regulation*

C. Tsang, X. Zheng, 2009, The Journal of Biological Chemistry.

Compacting DNA During the Interphase: Condensin Maintains rDNA Integrity

C. Tsang, Yuehua Wei, X. Zheng, 2007, Cell cycle.

PP 2 AC Level Determines Differential Programming of p 38-TSC-mTOR Signaling and Therapeutic Response to p 38-Targeted Therapy in Colorectal Cancer

E. White, X. Zheng, F. Liu, 2015 .

Sch9 partially mediates TORC1 signaling to control ribosomal RNA synthesis

Yuehua Wei, X. Zheng, Steven Zheng, 2009, Cell cycle.

Construction of a low-serine-type-carboxypeptidase-producing mutant of Aspergillus oryzae by the expression of antisense RNA and its use as a host for heterologous protein secretion

M. Takeuchi, X. Zheng, Y. Kobayashi, 1998, Applied Microbiology and Biotechnology.

Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis

Xiao-Xing Li, Hui-Yun Wang, X. S. Zheng, 2021, Hepatology.

TOR-in(g) the Nucleus

C. Tsang, X. Zheng, X. S. Zheng, 2007, Cell cycle.

Regulation of APG14 Expression by the GATA-type Transcription Factor Gln3p*

X. Zheng, Paula G. Bertram, W. Ai, 2001, The Journal of Biological Chemistry.

Domains of Gln3p Interacting with Karyopherins, Ure2p, and the Target of Rapamycin Protein*

X. Zheng, J. Carvalho, 2003, The Journal of Biological Chemistry.

Target of rapamycin proteins and their kinase activities are required for meiosis.

S. Schreiber, X. Zheng, Xiaofeng Zheng, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Rab1A is an mTORC1 activator and a colorectal oncogene.

Hui-Yun Wang, Yuehua Wei, X. Zheng, 2014, Cancer cell.

Amino acids control blood glucose levels through mTOR signaling.

S. Libutti, S. Burley, X. Zheng, 2022, European journal of cell biology.

Rab1A Is an mTORC1 Activator and a Colorectal Oncogene.

Hui-Yun Wang, Yuehua Wei, X. Zheng, 2016, Cancer cell.

Mechanisms of regulation of RNA polymerase III‐dependent transcription by TORC1

C. Tsang, Yuehua Wei, X. Zheng, 2009, The EMBO journal.

Tripartite Regulation of Gln 3 p by TOR , Ure 2 p , and Phosphatases *

X. Zheng, C. Zeng, Paula G. Bertram, 2000 .

EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma

Hui-Yun Wang, X. Zheng, Hui-zhong Zhang, 2015, PloS one.

Overexpression of Rab 1 B and MMP 9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer

Xiao-Xing Li, Hui-Yun Wang, X. Zheng, 2017 .

Yin and yang of 4E-BP1 in cancer

S. Ganesan, X. Zheng, Ren-Tsung Wang, 2016, Cell cycle.

Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer

S. Burley, X. Zheng, Xiaoyang Su, 2022, Antioxidants.

Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

S. Schreiber, X. Zheng, E. Brown, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Identification of the abscisic acid receptor VvPYL1 in Vitis vinifera.

G. Li, Z. Hu, X. Zheng, 2011, Plant biology.

PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer.

E. White, X. Zheng, F. Liu, 2015, EBioMedicine.

Convergence of TOR-Nitrogen and Snf1-Glucose Signaling Pathways onto Gln3

X. Zheng, Ting-Fung Chan, X. F. Steven Zheng, 2002, Molecular and Cellular Biology.

Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance

C. Tsang, X. Zheng, Chi Kwan Tsang, 2014, Nature Communications.

Regulation of subtelomeric silencing during stress response.

C. Tsang, X. Zheng, Paula G. Bertram, 2002, Molecular cell.

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

C. Tsang, X. Zheng, Leroy F. Liu, 2007, Drug discovery today.

Emerging Role of Micrornas in Mtor Signaling Keywords Mtor · Microrna · Cancer · Cell Signaling Pathway · Biomarker

Hui-Yun Wang, X. Zheng, Yanjie Zhang, 2022 .

TOR Regulates Cell Death Induced by Telomere Dysfunction in Budding Yeast

Chao-Po Lin, X. Zheng, Leroy F. Liu, 2008, PloS one.

Gln3 Snf1-Glucose Signaling Pathways onto Convergence of TOR-Nitrogen and

X. Zheng, Paula G. Bertram, Jae H. Choi, 2014 .

Phosphorylation Regulates the Interaction between Gln3p and the Nuclear Import Factor Srp1p*

X. Zheng, Paula G. Bertram, S. Wente, 2001, The Journal of Biological Chemistry.

Tripartite Regulation of Gln3p by TOR, Ure2p, and Phosphatases*

X. Zheng, C. Zeng, Paula G. Bertram, 2000, The Journal of Biological Chemistry.

Nutrient regulates Tor1 nuclear localization and association with rDNA promoter

C. Tsang, X. Zheng, Hong Li, 2006, Nature.

A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

M. Johnston, L. Riles, S. Korsmeyer, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin.

X. Zheng, Xiangyu Liu, 2007, Molecular biology of the cell.

FKBP12-Rapamycin-associated Protein or Mammalian Target of Rapamycin (FRAP/mTOR) Localization in the Endoplasmic Reticulum and the Golgi Apparatus*

X. Zheng, R. Drenan, Paula G. Bertram, 2004, Journal of Biological Chemistry.

SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage

Zhiyuan Shen, C. Tsang, H. Inuzuka, 2016, Nucleic acids research.

p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis

Xiao-Xing Li, Yang Yang, Hui-Yun Wang, 2017, Cell cycle.

Targeting the mTOR kinase domain: the second generation of mTOR inhibitors.

X. Zheng, X. Zheng, Yanwen Duan, 2011, Drug discovery today.

Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase.

S. Burley, X. Zheng, J. Kerrigan, 2015, Cell reports.

Identification of a Non-Ga tekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase Graphical

S. Burley, X. Zheng, J. Kerrigan, 2015 .

Expanding roles of superoxide dismutases in cell regulation and cancer.

Hui-Yun Wang, X. Zheng, Xiaoxing Li, 2016, Drug discovery today.

Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries.

W. Young, C. Tsang, X. Zheng, 2012, Drug discovery today.

Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells

X. Zheng, Li Xu, Hai-Shan Peng, 2014, PloS one.

Reduced SOD 2 expression is associated with mortality of hepatocellular carcinoma patients in a mutant p 53 ‐ dependent manner

Xiao-Xing Li, Yang Yang, X. Zheng, 2016 .

SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.

Xiaoxing Li, Stephen K Burley, Brinda Vallat, 2018, Molecular cell.

PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer

E. White, F. Liu, X. Zheng, 2015, EBioMedicine.

Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma.

S. Burley, X. Zheng, K. Spencer, 2021, Drug discovery today.

SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage

Zhiyuan Shen, C. Tsang, H. Inuzuka, 2016, Nucleic acids research.

SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.

S. Burley, E. White, Brinda K. Vallat, 2018, Molecular cell.

TORC1 association with rDNA chromatin as a mechanism to co-regulate Pol I and Pol III

Yuehua Wei, X. Zheng, 2009, Cell cycle.

Mechanisms of regulation of RNA polymerase III‐dependent transcription by TORC1

C. Tsang, Yuehua Wei, X. Zheng, 2009, The EMBO journal.

Abstract 2053: Overexpressed Rab1A is associated poor prognosis and promotes oncogenic growth and metastasis through mTORC1 activation in hepatocellular carcinoma

X. Zheng, Bingwei Xu, Hui‐Yun Wang, 2015 .